Children with low-risk acute lymphoblastic leukemia are at highest risk of second cancers

Pediatric Blood & Cancer
Stine Nygaard NielsenKjeld Schmiegelow

Abstract

The improved survival rates for childhood acute lymphoblastic leukemia (ALL) may be jeopardized by the development of a second cancer, which has been associated with thiopurine therapy. We retrospectively analyzed three sequential Nordic Society of Paediatric Haematology and Oncology's protocols characterized by increasing intensity of thiopurine-based maintenance therapy. We explored the risk of second cancer in relation to protocols, risk group, thiopurine methyltransferase (TPMT) activity, ALL high hyperdiploidy (HeH), and t(12;21)[ETV6/RUNX1]. After median 9.5 years (interquartile range, 5.4-15.3 yrs) of follow-up, 40 of 3,591 patients had developed a second cancer, of whom 38 had non-high-risk B-cell precursor ALL. Patients with standard-risk ALL, who received the longest maintenance therapy, had the highest adjusted hazard of second cancer (hazard ratio [HR], intermediate vs. standard risk: 0.16, 95% CI: 0.06-0.43, P < 0.001; HR, high vs. standard risk: 0.09, 95% CI: 0.02-0.49, P = 0.006); no significant effects of protocol, age, or white blood cell count at diagnosis, ALL HeH, or t(12;21)[ETV6/RUNX1] were observed. A subset analysis on the patients with standard-risk ALL did not show an increased hazard of second cancer ...Continue Reading

References

Dec 12, 1991·The New England Journal of Medicine·C H PuiJ T Sandlund
Aug 1, 1996·Controlled Clinical Trials·M Schemper, T L Smith
Aug 1, 1997·Biochemical Pharmacology·S Uribe-LunaJ A Nelson
Apr 30, 1999·Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology·E ForestierG Roos
Nov 7, 1999·Lancet·J L WiemelsM F Greaves
Apr 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W E EvansM V Relling
Aug 17, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Debra L FriedmanLouise C Strong
Aug 17, 2006·Journal of Pediatric Hematology/oncology·Erik ForestierUNKNOWN Nordic Society of Paediatric Haematology and Oncology NOPHO
Mar 22, 2007·JAMA : the Journal of the American Medical Association·Nobuko HijiyaChing-Hon Pui
Mar 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anna T MeadowsPeter D Inskip
May 28, 2009·Journal of the National Cancer Institute·Jørgen H OlsenStanislaw Garwicz
Aug 4, 2009·Journal of Pediatric Hematology/oncology·Kjeld SchmiegelowUNKNOWN Nordic Society of Paediatric Haematology and Oncology (NOPHO)
Oct 2, 2009·International Journal of Laboratory Hematology·P Rachieru-SourisseauA Chassevent
Dec 17, 2009·Leukemia·K SchmiegelowUNKNOWN Nordic Society of Paediatric Haematology and Oncology
May 5, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine J HarrisonBrenda E S Gibson
Jul 4, 2012·Journal of Cancer Research and Clinical Oncology·Nina ErčuljVita Dolžan
Feb 5, 2013·Nature Genetics·Julia A MeyerWilliam L Carroll
May 22, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kjeld SchmiegelowMaria Grazia Valsecchi
Jun 12, 2013·Journal of Cancer Survivorship : Research and Practice·Stephanie M PerkinsHaydar Frangoul
Nov 16, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Thomas Leth FrandsenKjeld Schmiegelow
Jan 8, 2014·Pediatric Blood & Cancer·Mette LevinsenUNKNOWN Nordic Society of Paediatric Haematology, Oncology
Mar 31, 2015·British Journal of Haematology·Julie D SandahlHenrik Hasle
Oct 28, 2016·Cancer Chemotherapy and Pharmacology·Stine Nygaard NielsenKjeld Schmiegelow

❮ Previous
Next ❯

Citations

Aug 15, 2018·Oncogene·Oksana GoroshchukCaroline Palm-Apergi

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.